PROACTIVE GCP COMPLIANCE
December 14–16, 2020
BROUGHT TO YOU BY
Effective Risk-Based Approaches for Optimizing
Clinical Quality and Achieving Inspection Readiness
This annual forum is for both senior-level clinical quality and clinical operations executives to gather, learn and discuss strategies to achieve and maintain global GCP compliance. Join us to learn how to effectively build quality risk management approaches into your clinical operations to optimize research, maintain GCP compliance, contain costs and ensure patient safety.
"This was probably the best industry conference I have attended. It was well worth attending and featured many talented speakers who shared their valuable expertise. I learned a great deal."
—Associate Director, R&D Compliance, BIOGEN
Conference Chair
Returning for her fourth year as conference chair
Joanne Spallone
Global Development Quality Audit Head
NOVARTIS
Featured Speakers
Kathleen L. O'Donnell, BSN
Head, Global R&D Clinical QMS Process Improvement
BRISTOL-MYERS SQUIBB
Angela Repa
Director, Proactive Clinical Excellence
BLUEBIRD BIO
Sharon Crugnale
Executive Director, Head of Clinical Operations
SAREPTA THERAPEUTICS
Scott Litrakis
Head of Clinical Compliance and Risk Management
BRISTOL-MYERS SQUIBB
MyLe Hoang
Director, Quality Assurance, Infection Disease/Vaccines
MERCK
Audience Demographics
Company Type
Pharmaceutical, Biotechnology and Device Companies
Contract Research Organizations (CROs)
Other Clinical Service Providers
Other
Primary Functional Area
Clinical Quality/Compliance
Clinical Operations
Other
